July 30, 2008 - Researchers at the Ohio State University Medical Center have designed equipment to provide high resolution images of the heart at peak stress level - a critical stage of testing - that have previously been difficult to obtain using standard testing procedures.

Now superior images of the heart are obtained with a test lasting less than one hour.

July 30, 2008 - Having completed clinical trials of its ThromboGuide (T-Guide) Platelet aggregation system, ThromboVision Inc. has filed a 510(k) market clearance review application with the FDA.

July 29, 2008 - The American College of Chest Physicians (ACCP) recently published new evidence-based clinical guidelines for physicians that for the first time suggest the use of pharmacomechanical thrombolysis for acute iliofemoral deep vein thrombosis (DVT) in conjunction with anticoagulation drug therapy.

The new guidelines appear in the July supplement to the CHEST journal.

July 29, 2008 - For several years, doctors have known that certain stem cells migrate to the heart after a heart attack, but exactly how they get there and what purpose they serve remained uncertain.

July 29, 2008 - The Journal of Emergency Medical Services (JEMS) recently named Physio-Control’s LIFENET STEMI Management Solution, a combination of Web, broadband and medical technology, that reduces time to treatment for heart attack patients as one of its “Hot Products for 2008.”

July 28, 2008 - Geneva College, Beaver Falls, PA, will launch the first Cardiovascular Technology (CVT) graduate degree program in the nation.

In affiliation with INOVA Fairfax Hospital in Falls Church, VA, the program offers students a M.S. degree in Cardiovascular Sciences. Geneva's incoming freshmen this fall will have the option of obtaining a B.S. (in four years) or a B.S./M.S. degree (in five years) in CVT. Students coming into the program with another B.S. degree can complete the M.S. in two years.

July 28, 2008 - Concentric Medical Inc. today said it launched its “V” series of Merci Retrievers, available in multiple configurations and sizes to match patient anatomy to remove blood clots and help restore blood flow in patients who have suffered ischemic strokes.

July 28, 2008 - OrbusNeich today added the Sapphire NC coronary dilatation non-compliant balloon catheter to its product line-up with the receipt of CE Mark approval.

The Sapphire NC has controlled growth of only 0.6 percent per atmosphere of pressure over the working pressure range for controlled dilatations. Furthermore, it has a high 22 atmospheres rated burst pressure for confident treatment of tough, calcified lesions and for post-stent dilatation.

July 25, 2008 - CryoCath Technologies Inc. said this week results previously presented from three European study centers using the company’s Arctic Front, a cryotherapy product to treat cardiac arrhythmias, were published in the Journal of the American College of Cardiology (JACC).

July 25, 2008 - The FDA granted 510(k) approval in June for numerous diagnostic and invasive cardiac devices, including both new devices and modified versions of existing equipment. Among the approvals were the following devices:

- CryoCath Technologies Inc. had its FlexCath Steerable Sheath and intended for percutaneous catheter introduction into the vasculature and into the chambers of the heart. The sheath deflection facilitates catheter positioning. It was previously approved to facilitate placing a catheter through the skin into the artery or vein.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now